Table 3.
Independent variables (referent) | Surveillance mammography N=2,998 |
---|---|
Eligibility (Medicare) | 1.00 |
Dual (Medicaid and Medicare) | 0.80 (0.57–1.11) |
Age (66–69 years) | 1.00 |
70–74 | 1.02 (0.78–1.33) |
75–79 | 0.90 (0.69–1.19) |
80–84 | 0.68 (0.50–0.92)* |
85+ | 0.34 (0.24–0.48)** |
Race (Caucasian) | 1.00 |
African American | 0.73 (0.50–1.05) |
Other | 1.39 (0.60–3.23) |
Stage at diagnosis (I) | 1.00 |
II | 0.73 (0.62–0.85)** |
Comorbidity (0) | 1.00 |
1 | 0.72 (0.56–0.92)** |
2 | 0.59 (0.40–0.86)** |
3 or more | 0.37 (0.21–0.64)** |
Education | 1.00 |
<12th Grade Education | 0.29 (0.11–1.09) |
BCS without Radiation ϕ | 1.00 |
BCS with radiation | 1.82 (1.48–2.24)** |
No Physician visit within 1 year post treatment α | 1.00 |
Physician visit within 1 year post treatment | 4.44 (2.89–6.83)** |
The regression model also includes annual household income, number of radiation oncologists and number of general Practitioners/100,000 persons, percent minority composition of community, and rural/urban status
p<0.01 χ2 likelihood ratio test
p<0.001 χ2 likelihood ratio test
Excludes those with mastectomy
Post treatment refers to the 12 months after last treatment received